妊娠合并急性胰腺炎一例
A Case of Pregnancy Complicated with Acute Pancreatitis
DOI: 10.12677/acm.2024.14123245, PDF,    科研立项经费支持
作者: 唐浴鹃*, 古艳菲*, 林伟钊#, 马雪枫#：暨南大学附属第一医院妇产科，广东 广州
关键词: 急性胰腺炎；高甘油三酯血症；妊娠并发症；病例报告；Acute Pancreatitis； Hypertriglyceridemia； Pregnancy Complications； Case Report
摘要: 妊娠合并急性胰腺炎是一种少见但潜在严重的疾病，甚至可能危及母婴生命。因此及时诊断和有效治疗对改善母婴预后十分重要。胆结石疾病与高甘油三酯血症是妊娠合并急性胰腺炎的常见病因。其中并发症风险最大的是由高甘油三酯血症引起的急性胰腺炎。此种类型胰腺炎的治疗重难点在妊娠期高脂血症的管理。目前国内外尚无指南。本文报道了一例妊娠合并急性胰腺炎的患者，并探讨了其诊断和治疗策略。本案例患者在使用双重血浆置换、非诺贝特、omega-3脂肪酸等降脂药物及其他治疗后病情得到显著改善，顺利分娩一活婴，为该疾病的诊治和妊娠期高脂血症的管理提供了很好的参考意义。
Abstract: Acute pancreatitis during pregnancy is a rare but potentially serious disease that may even endanger the life of the mother and child. Therefore, timely diagnosis and effective treatment are very important to improve maternal and infant prognosis. Gallstone disease and hypertriglyceridemia are common causes of acute pancreatitis during pregnancy. The highest risk of complications is acute pancreatitis caused by hypertriglyceridemia. The treatment of this type of pancreatitis is difficult in the management of hyperlipidemia during pregnancy. At present, there are no guidelines at home or abroad. This article reports a case of pregnancy complicated with acute pancreatitis, and discusses its diagnosis and treatment strategy. In this case, the patient’s condition was significantly improved after the use of lipid-lowering drugs such as double plasma exchange, fenofibrate, omega-3 fatty acids and other treatments, and a live baby was delivered successfully, which provided a good reference for the diagnosis and treatment of this disease and the management of hyperlipidemia during pregnancy.
文章引用：唐浴鹃, 古艳菲, 林伟钊, 马雪枫. 妊娠合并急性胰腺炎一例[J]. 临床医学进展, 2024, 14(12): 1498-1504. https://doi.org/10.12677/acm.2024.14123245

参考文献

[1] Cruciat, G., Nemeti, G., Goidescu, I., Anitan, S. and Florian, A. (2020) Hypertriglyceridemia Triggered Acute Pancreatitis in Pregnancy—Diagnostic Approach, Management and Follow-Up Care. Lipids in Health and Disease, 19, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[2] Rawla, P., Sunkara, T., Thandra, K.C. and Gaduputi, V. (2018) Hypertriglyceridemia-induced Pancreatitis: Updated Review of Current Treatment and Preventive Strategies. Clinical Journal of Gastroenterology, 11, 441-448. [Google Scholar] [CrossRef] [PubMed]
[3] Russi, G. (2015) Severe Dyslipidemia in Pregnancy: The Role of Therapeutic Apheresis. Transfusion and Apheresis Science, 53, 283-287. [Google Scholar] [CrossRef] [PubMed]
[4] Banks, P.A., Bollen, T.L., Dervenis, C., Gooszen, H.G., Johnson, C.D., Sarr, M.G., et al. (2012) Classification of Acute Pancreatitis—2012: Revision of the Atlanta Classification and Definitions by International Consensus. Gut, 62, 102-111. [Google Scholar] [CrossRef] [PubMed]
[5] (2013) IAP/APA Evidence-Based Guidelines for the Management of Acute Pancreatitis. Pancreatology, 13, e1-15.
[6] 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021) [J]. 浙江实用医学, 2021, 26(6): 511-519, 535.
[7] Mach, F., Baigent, C., Catapano, A.L., Koskinas, K.C., Casula, M., Badimon, L., et al. (2019) 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 41, 111-188. [Google Scholar] [CrossRef] [PubMed]
[8] Gupta, M., Liti, B., Barrett, C., Thompson, P.D. and Fernandez, A.B. (2022) Prevention and Management of Hypertriglyceridemia-Induced Acute Pancreatitis during Pregnancy: A Systematic Review. The American Journal of Medicine, 135, 709-714. [Google Scholar] [CrossRef] [PubMed]
[9] Lewek, J. and Banach, M. (2022) Dyslipidemia Management in Pregnancy: Why Is It Not Covered in the Guidelines? Current Atherosclerosis Reports, 24, 547-556. [Google Scholar] [CrossRef] [PubMed]
[10] Lent-Schochet, D. and Jialal, I. (2024) Antilipemic Agent Bile Acid Sequestrants. StatPearls.
[11] Ast, M. and Frishman, W.H. (1990) Bile Acid Sequestrants. The Journal of Clinical Pharmacology, 30, 99-106. [Google Scholar] [CrossRef] [PubMed]
[12] Dostal, L.A., Schardein, J.L. and Anderson, J.A. (1994) Developmental Toxicity of the HMG‐COA Reductase Inhibitor, Atorvastatin, in Rats and Rabbits. Teratology, 50, 387-394. [Google Scholar] [CrossRef] [PubMed]
[13] Winterfeld, U., Allignol, A., Panchaud, A., Rothuizen, L., Merlob, P., Cuppers‐Maarschalkerweerd, B., et al. (2012) Pregnancy Outcome Following Maternal Exposure to Statins: A Multicentre Prospective Study. BJOG: An International Journal of Obstetrics & Gynaecology, 120, 463-471. [Google Scholar] [CrossRef] [PubMed]
[14] Halpern, D.G., Weinberg, C.R., Pinnelas, R., Mehta-Lee, S., Economy, K.E. and Valente, A.M. (2019) Use of Medication for Cardiovascular Disease during Pregnancy. Journal of the American College of Cardiology, 73, 457-476. [Google Scholar] [CrossRef] [PubMed]
[15] Nordgren, T., Lyden, E., Anderson-Berry, A. and Hanson, C. (2017) Omega-3 Fatty Acid Intake of Pregnant Women and Women of Childbearing Age in the United States: Potential for Deficiency? Nutrients, 9, Article 197. [Google Scholar] [CrossRef] [PubMed]
[16] Jacobson, T.A. (2008) Role of N-3 Fatty Acids in the Treatment of Hypertriglyceridemia and Cardiovascular Disease. The American Journal of Clinical Nutrition, 87, 1981S-1990S. [Google Scholar] [CrossRef] [PubMed]
[17] Middleton, P., Gomersall, J.C., Gould, J.F., Shepherd, E., Olsen, S.F. and Makrides, M. (2018) ω-3 Fatty Acid Addition during Pregnancy. Cochrane Database of Systematic Reviews, No. 11, CD003402. [Google Scholar] [CrossRef] [PubMed]
[18] Whitten, A.E., Lorenz, R.P. and Smith, J.M. (2011) Hyperlipidemia-Associated Pancreatitis in Pregnancy Managed with Fenofibrate. Obstetrics & Gynecology, 117, 517-519. [Google Scholar] [CrossRef] [PubMed]
[19] Lloret Linares, C., Pelletier, A.L., Czernichow, S., Vergnaud, A.C., Bonnefont-Rousselot, D., Levy, P., et al. (2008) Acute Pancreatitis in a Cohort of 129 Patients Referred for Severe Hypertriglyceridemia. Pancreas, 37, 13-2. [Google Scholar] [CrossRef] [PubMed]
[20] Regitz-Zagrosek, V., Roos-Hesselink, J.W., Bauersachs, J., Blomstrom-Lundqvist, C., Cifkova, R., De Bonis, M., et al. (2019) 2018 ESC Guidelines for the Management of Cardiovascular Diseases during Pregnancy. Kardiologia Polska, 77, 245-326. [Google Scholar] [CrossRef] [PubMed]
[21] Taylor, K.W. (1972) Metabolic Changes in the Islets of Langerhans in Relationship to the Onset of Diabetes Mellitus. Diabetologia, 8, 236-243. [Google Scholar] [CrossRef] [PubMed]

为你推荐